poractant alfa 80 MG/ML Intratracheal Suspension

RxCUI: 259216
RxNorm name: poractant alfa 80 MG/ML Intratracheal Suspension
Display name: poractant alfa 80 MG/ML Intratracheal Suspension
Full name: poractant alfa 80 MG/ML Intratracheal Suspension
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:10

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
020744	Curosurf	poractant alfa	351(a)	Rx	2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Curosurf	PORACTANT ALFA	Chiesi USA, Inc.	99bef307-00bd-4379-9f45-ede1380e74d4	2025-12-10	Warnings, Adverse reactions	Exact identifier rxcui: 259216

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
99bef307-00bd-4379-9f45-ede1380e74d4	poractant alfa 80 MG/ML Intratracheal Suspension [PSN] · poractant alfa 80 MG/ML Intratracheal Suspension [SCD]	2	45	These highlights do not include all the information needed to use CUROSURF ® safely and effectively. See full prescribing information for CUROSURF. CUROSURF (poractant alfa) intratracheal suspension Initial U.S. Approval: 1999	20251210